News HIV Patient’s Detectable Viremia Linked to ART-Supplement Interaction By Cassandra Pardini, PharmD Publish Date January 14, 2021
Generics News Merzee, a Generic Equivalent of Taytulla, Approved for Pregnancy Prevention By Brian Park, PharmD Publish Date December 22, 2020
Drugs in the Pipeline Oteseconazole Promising for Recurrent Vulvovaginal Candidiasis By Brian Park, PharmD Publish Date December 10, 2020
Drugs in the Pipeline Ibrexafungerp Gets Priority Review for Vulvovaginal Candidiasis By Brian Park, PharmD Publish Date December 8, 2020
Drugs in the Pipeline Secnidazole Under Review for Trichomoniasis By Brian Park, PharmD Publish Date November 16, 2020
Generics News Generic Version of Oral Contraceptive Taytulla Gets Approval By Steve Duffy Publish Date November 11, 2020
Safety Alerts and Recalls FDA: NSAID Use Should Be Avoided in Pregnancy Even Sooner Than 30 Weeks By Brian Park, PharmD Publish Date October 16, 2020
Drugs in the Pipeline Ibrexafungerp NDA for Vulvovaginal Candidiasis Submitted for Review By Brian Park, PharmD Publish Date October 16, 2020
Safety Alerts and Recalls FDA Proposes Makena Be Withdrawn From the Market By Brian Park, PharmD Publish Date October 7, 2020
News Modafinil in Early Pregnancy Not Tied to Congenital Malformations Publish Date September 14, 2020
News Phexxi, a Vaginal pH Regulator, Now Available for Pregnancy Prevention By Brian Park, PharmD Publish Date September 8, 2020
News NAMS 2020 Genitourinary Syndrome of Menopause Position Statement Released By Cassandra Pardini, PharmD Publish Date September 8, 2020
News Mirena Approved for Pregnancy Prevention for Up to 6 Years By Brian Park, PharmD Publish Date August 25, 2020
News FDA to Review Relugolix Combination Therapy for Uterine Fibroids By Brian Park, PharmD Publish Date August 18, 2020
Drugs in the Pipeline Study Findings Support Use of Secnidazole for Trichomoniasis By Brian Park, PharmD Publish Date August 17, 2020